CRAF GENE MUTATION
Clinical trials for CRAF GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new CRAF GENE MUTATION trials appear
Sign up with your email to follow new studies for CRAF GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer pill shows early promise but study halted
Disease control TerminatedThis early-phase study tested an experimental oral drug called IK-595 in 75 adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have specific RAS or RAF gene mutations. The goal was to check safety, find the right dose, and see if it shrinks tumor…
Matched conditions: CRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated May 17, 2026 01:44 UTC
-
New cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage trial tested a new drug called DCC-3084, alone or with other cancer treatments, in 29 people with advanced solid tumors that have specific genetic changes (MAPK pathway). The study was stopped early, so results are limited. The goal was to find safe doses and see…
Matched conditions: CRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 13, 2026 16:04 UTC